Home > Financial Ratios > BIOCON
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 2.572.452.061.311.36

What is the latest Fixed Capital/Sales ratio of BIOCON ?

The latest Fixed Capital/Sales ratio of BIOCON is 2.57 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20252.57
Mar20242.45
Mar20232.06
Mar20221.31
Mar20211.36

How is Fixed Capital/Sales of BIOCON Trending?

Years Fixed Capital/Sales % Change
Mar2025 2.57
4.90
Mar2024 2.45
18.93
Mar2023 2.06
57.25
Mar2022 1.31
-3.68
Mar2021 1.36 -

Other Financial Ratios of BIOCON


Compare Fixed Capital/Sales ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹49,736.4 Cr 3.4% 9.1% 16.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,452.0 Cr -0.3% 6% -10.5% Stock Analytics
DIVIS LABORATORIES ₹179,089.0 Cr 3.9% 18.6% 14.5% Stock Analytics
CIPLA ₹121,299.0 Cr -5.2% NA 2.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,456.0 Cr -1% -1.2% 8.7% Stock Analytics
DR REDDYS LABORATORIES ₹99,965.9 Cr -6.8% -2.1% -8.4% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

3.4%

9.1%

16.6%

SENSEX

-0.3%

4.5%

5.7%


You may also like the below Video Courses